RBC Europe’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-97
Closed -$23.5K – 841
2021
Q3
$23.5K Hold
97
– – ﹤0.01% 745
2021
Q2
$20.1K Hold
97
– – ﹤0.01% 815
2021
Q1
$18.3K Hold
97
– – ﹤0.01% 791
2020
Q4
$16K Buy
+97
New +$14.2K ﹤0.01% 774
2020
Q1
– Sell
-230
Closed -$34K – 1067
2019
Q4
$34K Hold
230
– – ﹤0.01% 538
2019
Q3
$27.7K Hold
230
– – ﹤0.01% 566
2019
Q2
$31.1K Hold
230
– – ﹤0.01% 562
2019
Q1
$30K Hold
230
– – ﹤0.01% 574
2018
Q4
$28.6K Hold
230
– – ﹤0.01% 548
2018
Q3
$32K Hold
230
– – ﹤0.01% 578
2018
Q2
$23.6K Hold
230
– – ﹤0.01% 640
2018
Q1
$22.3K Hold
230
– – ﹤0.01% 651
2017
Q4
$20.2K Hold
230
– – ﹤0.01% 679
2017
Q3
$18.3K Buy
+230
New +$18.5K ﹤0.01% 701

Other funds holding HCA

RBC Europe's HCA Position: Q4 2021 in Review

RBC Europe sold out of HCA Healthcare (HCA) in Q4 2021, closing a stake of 97 shares — an estimated $23.5K sold.

RBC Europe first reported a position in HCA in Q3 2017 and held it in 14 quarters. The position peaked at $34K in Q4 2019. 947 funds tracked by Wall St. Rank hold HCA as of Q4 2021.

  • RBC Europe reported no remaining HCA Healthcare position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 97 HCA Healthcare shares in Q4 2021, an estimated $23.5K.
  • RBC Europe first reported a position in HCA Healthcare in Q3 2017 and held it in 14 quarters.
  • RBC Europe's HCA Healthcare position peaked at $34K in Q4 2019.
  • 947 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.